Colonic CD8 and γδ T-cell infiltration with epithelial damage in children with autism☆☆☆
Abstract
Objectives: We have reported colitis with ileal lymphoid nodular hyperplasia (LNH) in children with regressive autism. The aims of this study were to characterize this lesion and determine whether LNH is specific for autism. Methods: Ileo-colonoscopy was performed in 21 consecutively evaluated children with autistic spectrum disorders and bowel symptoms. Blinded comparison was made with 8 children with histologically normal ileum and colon, 10 developmentally normal children with ileal LNH, 15 with Crohn’s disease, and 14 with ulcerative colitis. Immunohistochemistry was performed for cell lineage and functional markers, and histochemistry was performed for glycosaminoglycans and basement membrane thickness. Results: Histology demonstrated lymphocytic colitis in the autistic children, less severe than classical inflammatory bowel disease. However, basement membrane thickness and mucosal γδ cell density were significantly increased above those of all other groups including patients with inflammatory bowel disease. CD8+ density and intraepithelial lymphocyte numbers were higher than those in the Crohn’s disease, LNH, and normal control groups; and CD3 and plasma cell density and crypt proliferation were higher than those in normal and LNH control groups. Epithelial, but not lamina propria, glycosaminoglycans were disrupted. However, the epithelium was HLA-DR–, suggesting a predominantly TH2 response. Interpretation: Immunohistochemistry confirms a distinct lymphocytic colitis in autistic spectrum disorders in which the epithelium appears particularly affected. This is consistent with increasing evidence for gut epithelial dysfunction in autism. (J Pediatr 2001;138:366-72)
Abbreviations: GAGs , Glycosaminoglycans, GI , Gastrointestinal, IBD , Inflammatory bowel disease, LNH , Lymphoid nodular hyperplasia, UC , Ulcerative colitis
To access this article, please choose from the options below
☆ Supported by the Swiss National Science Foundation, M. und W. Lichtenstein-Stiftung, FAG Basel, Ciba-Geigy Jubiläums-Stiftung and Akademische Nachwuchsförderung der Universität Basel Switzerland (Dr Furlano) and by the Bailey Thomas Charitable Fund, the Basil Samuel Charitable Trust, the Normanby Charitable Trust, PF Charitable Trust, and the Sir Samuel Scott of Yews Charitable Trust.
☆☆ Reprint requests: Simon Murch, PhD, FRCP, FRCPCH, University Department of Paediatric Gastroenterology, Royal Free and University College Medical School, Royal Free Campus, Rowland Hill St, London, NW3 2PF United Kingdom.
PII: S0022-3476(01)92227-9
doi:10.1067/mpd.2001.111323
© 2001 Mosby, Inc. All rights reserved.
